Related Experiment Videos
[Daptomycin in Gram-positive bacterial infections in oncohematological patients and transplant recipients]
Jordi Carratalà1, Oscar Len, Julián de la Torre-Cisneros
1Servicio de Enfermedades Infecciosas, Hospital Universitari de Bellvitge-IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, España. jcarratala@ub.edu
Abstract:
Gram-positive infections are a major cause of morbidity and mortality in oncohematological patients and transplant recipients. The most frequently isolated Gram-positive organisms are the coagulase-negative staphylococci, Staphylococcus aureus and Enterococcus spp., and viridans group streptococci. Antibiotic resistance in these organisms is increasing and poses a challenge to clinicians. Daptomycin is rapidly bactericidal against a broad spectrum of gram-positive bacteria, including strains resistant to other drugs. The present article reviews some aspects of Gram-positive infections in these immunocompromised patients and provides a detailed analysis of experience with daptomycin in the treatment of these infections.
Insights
Gram-positive infections pose significant risks for immunocompromised patients. Daptomycin offers a potent treatment option, effectively targeting resistant bacteria in oncohematological and transplant recipients.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Context:
- Gram-positive infections are a leading cause of illness and death in patients undergoing cancer treatment (oncohematology) and organ/stem cell transplantation.
- Key pathogens include coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus spp., and viridans group streptococci.
- Rising antibiotic resistance in these bacteria presents a critical clinical challenge.
Purpose:
- To review Gram-positive infections in immunocompromised populations.
- To analyze the clinical experience and efficacy of daptomycin for treating these infections.
Summary:
- Daptomycin demonstrates rapid bactericidal activity against a wide range of Gram-positive bacteria.
- This includes activity against strains resistant to other antibiotics.
- The review details daptomycin's application in oncohematological and transplant patients.
Impact:
- Highlights daptomycin as a crucial therapeutic option for difficult-to-treat Gram-positive infections.
- Informs clinical decision-making for managing infections in vulnerable patient groups.
- Addresses the growing concern of antibiotic resistance in critical care settings.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management